
BREAKING: Kimberly‑Clark Corporation has agreed to acquire Kenvue Inc
BREAKING: Kimberly‑Clark Corporation has agreed to acquire Kenvue Inc. — the parent company of Tylenol — in a staggering $48.7 billion cash-and-stock deal. What makes this move even more striking: it comes just weeks after renewed public controversy surrounding Tylenol…